Who owns ASSEMBLY BIOSCIENCES INC?
- Ticker: ASMB
- CUSIP Number: 045396207
Tip: Access positions for across all investors
Analyze quarterly positions in Assembly Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Assembly Biosciences stock
Who bought or sold ASSEMBLY BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gilead Sciences | 4.5M | $125M | 0% | Mar 2026 |
|
| Farallon Capital Management | 1.2M | $42M | 0% | Dec 2025 |
|
| RA Capital Management | 1.0M | $28M | 0% | Mar 2026 |
|
| Commodore Capital | 1.0M | $28M | 0% | Mar 2026 |
|
| Henderson Group | 849k | $24M | 13% | Mar 2026 |
|
| Paradigm Biocapital Advisors | 665k | $19M | 0% | Mar 2026 |
|
| Vanguard Group | 573k | $20M | 14% | Dec 2025 |
|
| Vanguard Capital Management | 490k | $14M | 100% | Mar 2026 |
|
| Point72 Asset Management | 344k | $9.5M | -43% | Mar 2026 |
|
| Blackstone Group | 297k | $8.2M | -7% | Mar 2026 |
|
| Parkman Healthcare Partners | 249k | $8.5M | -1% | Dec 2025 |
|
| Millennium Management | 234k | $6.5M | 138% | Mar 2026 |
|
| BlackRock | 203k | $5.6M | 5% | Mar 2026 |
|
| Stempoint Capital | 185k | $5.1M | 18% | Mar 2026 |
|
| Adage Capital Partners GP | 161k | $5.5M | 100% | Dec 2025 |
|
| Eversept Partners | 160k | $5.4M | 100% | Dec 2025 |
|
| Patient Square Capital | 136k | $3.8M | 7% | Mar 2026 |
|
| Geode Capital Management | 133k | $3.7M | 1% | Mar 2026 |
|
| Marshall Wace | 129k | $4.4M | 51% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 121k | $3.3M | 122% | Mar 2026 |
|
| Caption Management | 107k | $3.6M | -70% | Dec 2025 |
|
| Susquehanna International | 80k | $2.7M | -64% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 72k | $2.0M | 100% | Mar 2026 |
|
| Superstring Capital Management | 65k | $2.2M | 100% | Dec 2025 |
|
| Seven Fleet Capital Management | 56k | $1.6M | -24% | Mar 2026 |
|
| State Street Corporation | 53k | $1.8M | 18% | Dec 2025 |
|
| Monimus Capital Management | 48k | $1.3M | 26% | Mar 2026 |
|
| GSA Capital Partners | 45k | $1.3M | 255% | Mar 2026 |
|
| Qube Research & Technologies | 42k | $1.4M | 282% | Dec 2025 |
|
| Northern Trust | 41k | $1.4M | 3% | Dec 2025 |
|
| Arrowstreet Capital, Limited Partnership | 38k | $1.3M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 36k | $1.0M | 4% | Mar 2026 |
|
| Jane Street | 35k | $957k | -36% | Mar 2026 |
|
| Morgan Stanley | 33k | $917k | 47% | Mar 2026 |
|
| 683 Capital Management | 28k | $773k | 0% | Mar 2026 |
|
| Citadel Advisors | 25k | $706k | -23% | Mar 2026 |
|
| Barclays | 25k | $841k | 525% | Dec 2025 |
|
| Squarepoint Ops | 24k | $661k | 100% | Mar 2026 |
|
| Trexquant Investment | 23k | $631k | -20% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 22k | $604k | 5% | Mar 2026 |
|
| Two Sigma Investments | 21k | $570k | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 20k | $554k | 1% | Mar 2026 |
|
| Palumbo Wealth Management | 20k | $545k | -47% | Mar 2026 |
|
| Federated Investors | 19k | $525k | -26% | Mar 2026 |
|
| Vanguard Portfolio Management | 18k | $492k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 17k | $466k | 12% | Mar 2026 |
|
| Susquehanna Portfolio Strategies | 14k | $473k | 100% | Dec 2025 |
|
| Raymond James Financial | 13k | $445k | 100% | Dec 2025 |
|
| Brevan Howard Capital Management | 11k | $308k | 100% | Mar 2026 |
|
| Bank of America Corporation | 11k | $303k | 100% | Mar 2026 |
|
| Engineers Gate Manager | 10k | $353k | 100% | Dec 2025 |
|
| Renaissance Technologies | 9.2k | $314k | -94% | Dec 2025 |
|
| Canada Pension Plan Investment Board | 8.5k | $236k | 143% | Mar 2026 |
|
| OMERS Administration Corporation | 8.1k | $225k | -48% | Mar 2026 |
|
| Virtus Investment Advisers | 7.4k | $251k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 6.7k | $228k | 100% | Dec 2025 |
|
| Citigroup | 6.5k | $180k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 4.6k | $128k | 100% | Mar 2026 |
|
| Tower Research Capital | 607.00 | $21k | 100% | Dec 2025 |
|
| UBS Group | 364.00 | $10k | -96% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 260.00 | $7.2k | 0% | Mar 2026 |
|
| Aquatic Capital Management | 220.00 | $6.1k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 190.00 | $5.3k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 149.00 | $4.1k | 7350% | Mar 2026 |
|
| Advisor Group Holdings | 100.00 | $3.4k | 0% | Dec 2025 |
|
| Us Bancorp | 59.00 | $2.0k | 100% | Dec 2025 |
|
| Fifth Third Bancorp | 57.00 | $1.6k | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 55.00 | $1.5k | 0% | Mar 2026 |
|
| Hanson McClain Advisors | 32.00 | $1.1k | 100% | Dec 2025 |
|
| Royal Bank of Canada | 16.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Assembly Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Franklin Resources | Dec 2025 | 211k | $7.2M |
| Ellsworth Advisors | Dec 2025 | 30k | $889k |
| Eudaimonia Asset Management | Dec 2025 | 30k | $1.0M |
| Sei Investments | Dec 2025 | 18k | $604k |
| Bridgeway Capital Management | Sep 2025 | 15k | $390k |
| XTX Topco | Sep 2025 | 13k | $328k |
| Acadian Asset Management | Dec 2025 | 12k | $422k |
| Farther Finance Advisors | Dec 2025 | 154.00 | $5.2k |
| Quadrant Capital | Dec 2025 | 22.00 | $749.001000 |